KalVista Pharmaceuticals (NasdaqGM:KALV) Q1 2026 Earnings Call September 11, 2025 08:30 AM ET Company ParticipantsRyan Baker - Head - IRBenjamin Palleiko - Director & CEONicole Sweeny - CCOBrian Piekos - CFOPaul Matteis - MD & Head - Therapeutics ResearchTazeen Ahmad - MD - US Equity ResearchPete Stavropoulos - Director - Biotech Equity ResearchDebanjana Chatterjee - Vice PresidentConference Call ParticipantsStacy Ku - Biotechnology Equity Research AnalystMaury Raycroft - Equity Research AnalystWill Soghiki ...

KalVista Pharmaceuticals (NasdaqGM:KALV) Q1 2026 Earnings Call September 11, 2025 08:30 AM ET Company ParticipantsBen Palleiko - CEONicole Sweeny - CCOBrian Piekos - CFORyan Baker - Head of Investor RelationsConference Call ParticipantsSerge Belanger - AnalystNone - AnalystDevanjana Chatterjee - AnalystMaury Raycroft - AnalystStacy Koo - AnalystWilliam Dubin - AnalystPaul Matteis - Senior Biotechnology AnalystPete Stavropoulos - AnalystTazeen Ahmad - AnalystOperatorLadies and gentlemen, thank you for standi ...

KalVista Pharmaceuticals (NasdaqGM:KALV) Q1 2026 Earnings Call September 11, 2025 08:30 AM ET Speaker5Ladies and gentlemen, thank you for standing by. Welcome to KalVista Pharmaceuticals' operational update and first fiscal quarter financial results. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you would need to press star one one on your telephone. You will then hear an automate ...